Breast cancer, version 1.2016 Journal Article
| Authors: | Gradishar, W. J.; Anderson, B. O.; Balassanian, R.; Blair, S. L.; Burstein, H. J.; Cyr, A.; Elias, A. D.; Farrar, W. B.; Forero, A.; Giordano, S. H.; Goetz, M.; Goldstein, L. J.; Hudis, C. A.; Isakoff, S. J.; Marcom, P. K.; Mayer, I. A.; McCormick, B.; Moran, M.; Patel, S. A.; Pierce, L. J.; Reed, E. C.; Salerno, K. E.; Schwartzberg, L. S.; Smith, K. L.; Smith, M. L.; Soliman, H.; Somlo, G.; Telli, M.; Ward, J. H.; Shead, D. A.; Kumar, R. |
| Article Title: | Breast cancer, version 1.2016 |
| Abstract: | These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them. © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. |
| Keywords: | cancer chemotherapy; treatment response; patient selection; systemic therapy; cancer adjuvant therapy; preoperative care; consensus; breast cancer; practice guideline; cancer hormone therapy; accreditation; continuing education; premenopause; breast metastasis; human; female; article |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 13 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2015-12-01 |
| Start Page: | 1475 |
| End Page: | 1485 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26656517 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 3 February 2016 -- Source: Scopus |
Citation Impact
Related MSK Work